Skip to main content

Table 3 Multivariate analysis of clinicopathologic factors for overall survival of patients with nasopharyngeal carcinoma

From: Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma

   Total Dead % HR 95% C.I. for HR P-value
CD80/86 Negative 39 16 41.0 1.000     0.968
  Positive 11 0 0.0 0.000 0.000 - 6.853E+282  
T Stage 1 or 2 32 7 21.9 1.000     0.050
  3 or 4 18 9 50.0 2.892 1.001 - 8.353  
N Stage 0 or 1 24 5 20.8 1.000     0.065
  2 or 3 26 11 42.3 2.830 0.938 - 8.539  
Treatment RT 8 1 12.5 1.000     0.193
  CCRT 42 15 35.7 3.979 0.497 - 31.870  
  1. HR: Hazard Ratio
\